207 related articles for article (PubMed ID: 30213375)
1. Expression of Stem Cell Factor in Feline Mast Cell Tumour.
Sakurai M; Iwasa R; Sakai Y; Chambers JK; Uchida K; Morimoto M
J Comp Pathol; 2018 Aug; 163():6-9. PubMed ID: 30213375
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical characterization of feline mast cell tumors.
Mallett CL; Northrup NC; Saba CF; Rodriguez CO; Rassnick KM; Gieger TL; Childress MO; Howerth EW
Vet Pathol; 2013 Jan; 50(1):106-9. PubMed ID: 22492208
[TBL] [Abstract][Full Text] [Related]
3. Expression of KIT receptor in feline cutaneous mast cell tumors.
Rodriguez-Cariño C; Fondevila D; Segalés J; Rabanal RM
Vet Pathol; 2009 Sep; 46(5):878-83. PubMed ID: 19429979
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors.
Sabattini S; Bettini G
Vet Pathol; 2010 Jul; 47(4):643-53. PubMed ID: 20418469
[TBL] [Abstract][Full Text] [Related]
5. Kit receptor tyrosine kinase dysregulations in feline splenic mast cell tumours.
Sabattini S; Barzon G; Giantin M; Lopparelli RM; Dacasto M; Prata D; Bettini G
Vet Comp Oncol; 2017 Sep; 15(3):1051-1061. PubMed ID: 27278268
[TBL] [Abstract][Full Text] [Related]
6. Aberrant autophosphorylation of c-Kit receptor in canine mast cell tumor cell lines.
Takeuchi Y; Fujino Y; Watanabe M; Nakagawa T; Ohno K; Sasaki N; Sugano S; Tsujimoto H
Vet Immunol Immunopathol; 2010 Oct; 137(3-4):208-16. PubMed ID: 20591500
[TBL] [Abstract][Full Text] [Related]
7. Stem cell factor contributes to tumorigenesis of mast cells via an autocrine/paracrine mechanism.
Amagai Y; Tanaka A; Matsuda A; Jung K; Ohmori K; Matsuda H
J Leukoc Biol; 2013 Feb; 93(2):245-50. PubMed ID: 23125456
[TBL] [Abstract][Full Text] [Related]
8. Sensitive detection of the c-KIT c.1430G>T mutation by mutant-specific polymerase chain reaction in feline mast cell tumours.
Takanosu M; Sato M; Kagawa Y
Vet Comp Oncol; 2014 Jun; 12(2):138-42. PubMed ID: 22891713
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Minichromosome Maintenance Protein 7 and c-KIT as Prognostic Markers in Feline Cutaneous Mast Cell Tumours.
Dobromylskyj MJ; Rasotto R; Melville K; Smith KC; Berlato D
J Comp Pathol; 2015 Nov; 153(4):244-50. PubMed ID: 26385324
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.
Tamlin VS; Kessell AE; Mccoy RJ; Dobson EC; Smith TS; Hebart M; Brown L; Mitrovic D; Peaston AE
Aust Vet J; 2017 Oct; 95(10):386-391. PubMed ID: 28948627
[TBL] [Abstract][Full Text] [Related]
11. Autocrine/Paracrine Loop Between SCF
Annese T; Tamma R; Bozza M; Zito A; Ribatti D
Front Immunol; 2022; 13():794974. PubMed ID: 35140718
[TBL] [Abstract][Full Text] [Related]
12. The value of molecular expression of KIT and KIT ligand analysed using real-time polymerase chain reaction and immunohistochemistry as a prognostic indicator for canine cutaneous mast cell tumours.
Costa Casagrande TA; de Oliveira Barros LM; Fukumasu H; Cogliati B; Chaible LM; Dagli ML; Matera JM
Vet Comp Oncol; 2015 Mar; 13(1):1-10. PubMed ID: 23294979
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the fifth immunoglobulin-like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours.
Isotani M; Yamada O; Lachowicz JL; Tamura K; Yagihara H; Fujino Y; Ono K; Washizu T; Bonkobara M
Br J Haematol; 2010 Jan; 148(1):144-53. PubMed ID: 19804453
[TBL] [Abstract][Full Text] [Related]
14. In situ c-KIT mRNA quantification of canine cutaneous mast cell tumours and its relationship to prognostic factors.
Seung BJ; Cho SH; Kim SH; Bae MK; Lim HY; Sur JH
Vet Comp Oncol; 2021 Mar; 19(1):132-139. PubMed ID: 32926564
[TBL] [Abstract][Full Text] [Related]
15. RIN3 is a negative regulator of mast cell responses to SCF.
Janson C; Kasahara N; Prendergast GC; Colicelli J
PLoS One; 2012; 7(11):e49615. PubMed ID: 23185384
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of Kit receptor tyrosine kinase dysregulations in feline cutaneous mast cell tumors.
Sabattini S; Guadagni Frizzon M; Gentilini F; Turba ME; Capitani O; Bettini G
Vet Pathol; 2013 Sep; 50(5):797-805. PubMed ID: 23377219
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of KIT receptor and its ligand stem cell factor in Merkel cell carcinoma.
Krasagakis K; Kruger-Krasagakis S; Eberle J; Tsatsakis A; Tosca AD; Stathopoulos EN
Dermatology; 2009; 218(1):37-43. PubMed ID: 19001805
[TBL] [Abstract][Full Text] [Related]
18. Production of stem cell factor in canine mast cell tumors.
Amagai Y; Tanaka A; Jung K; Matsuda A; Oida K; Nishikawa S; Jang H; Ishizaka S; Matsuda H
Res Vet Sci; 2014 Feb; 96(1):124-6. PubMed ID: 24269079
[TBL] [Abstract][Full Text] [Related]
19. CD117 immunoexpression in canine mast cell tumours: correlations with pathological variables and proliferation markers.
Gil da Costa RM; Matos E; Rema A; Lopes C; Pires MA; Gärtner F
BMC Vet Res; 2007 Aug; 3():19. PubMed ID: 17711582
[TBL] [Abstract][Full Text] [Related]
20. All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours.
Meyer A; Gruber AD; Klopfleisch R
J Comp Pathol; 2013 Jul; 149(1):19-29. PubMed ID: 23276382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
